Page 11«..10111213..2030..»

Housing and infections affect genes that regulate pregnancy in female pigs – The Pig Site

Housing and infections affect genes that regulate pregnancy in female pigs  The Pig Site

Follow this link:
Housing and infections affect genes that regulate pregnancy in female pigs - The Pig Site

Recommendation and review posted by Bethany Smith

Eggs from men, sperm from women: Stem cell therapy may just turn reproduction upside down! – The Economic Times

Eggs from men, sperm from women: Stem cell therapy may just turn reproduction upside down!  The Economic Times

Follow this link:
Eggs from men, sperm from women: Stem cell therapy may just turn reproduction upside down! - The Economic Times

Recommendation and review posted by Bethany Smith

Herbosa: Clinic under probe after skin treatments linked to womans death – Philstar.com

Herbosa: Clinic under probe after skin treatments linked to womans death  Philstar.com

Here is the original post:
Herbosa: Clinic under probe after skin treatments linked to womans death - Philstar.com

Recommendation and review posted by Bethany Smith

AI at Davos, new CRISPR therapies and health tech’s bad marketing – Marketplace

AI at Davos, new CRISPR therapies and health tech's bad marketing  Marketplace

See the article here:
AI at Davos, new CRISPR therapies and health tech's bad marketing - Marketplace

Recommendation and review posted by Bethany Smith

FDA expands use of newly approved CRISPR therapy – Axios

FDA expands use of newly approved CRISPR therapy  Axios

See the original post here:
FDA expands use of newly approved CRISPR therapy - Axios

Recommendation and review posted by Bethany Smith

CRISPR-based therapy receives expanded approval for beta thalassemia – STAT

CRISPR-based therapy receives expanded approval for beta thalassemia  STAT

See original here:
CRISPR-based therapy receives expanded approval for beta thalassemia - STAT

Recommendation and review posted by Bethany Smith

CRISPR Therapeutics And Vertex’s CRISPR Breakthrough: How And Why They Got There First – Scrip

CRISPR Therapeutics And Vertex's CRISPR Breakthrough: How And Why They Got There First  Scrip

Continue reading here:
CRISPR Therapeutics And Vertex's CRISPR Breakthrough: How And Why They Got There First - Scrip

Recommendation and review posted by Bethany Smith

Pharmalittle: We’re reading about a CRISPR approval, selling meds directly to patients, and more – STAT

Pharmalittle: We're reading about a CRISPR approval, selling meds directly to patients, and more  STAT

See the original post:
Pharmalittle: We're reading about a CRISPR approval, selling meds directly to patients, and more - STAT

Recommendation and review posted by Bethany Smith

Here’s Why CRISPR Therapeutics Stock Rose 54% Last Year – The Motley Fool

Here's Why CRISPR Therapeutics Stock Rose 54% Last Year  The Motley Fool

Excerpt from:
Here's Why CRISPR Therapeutics Stock Rose 54% Last Year - The Motley Fool

Recommendation and review posted by Bethany Smith

Vertex’s CRISPR Gene Therapy Lands Another FDA Nod in a Rare Blood Disease – MedCity News

Vertex's CRISPR Gene Therapy Lands Another FDA Nod in a Rare Blood Disease  MedCity News

Read the rest here:
Vertex's CRISPR Gene Therapy Lands Another FDA Nod in a Rare Blood Disease - MedCity News

Recommendation and review posted by Bethany Smith

Groundbreaking CRISPR/Cas9-based Genome Editing Therapy Secured the Second FDA Approval – geneonline

Groundbreaking CRISPR/Cas9-based Genome Editing Therapy Secured the Second FDA Approval  geneonline

Link:
Groundbreaking CRISPR/Cas9-based Genome Editing Therapy Secured the Second FDA Approval - geneonline

Recommendation and review posted by Bethany Smith

What Does It Mean for Investors if CRISPR Therapeutics Gets Bought Out in 2024? – The Motley Fool

What Does It Mean for Investors if CRISPR Therapeutics Gets Bought Out in 2024?  The Motley Fool

See the article here:
What Does It Mean for Investors if CRISPR Therapeutics Gets Bought Out in 2024? - The Motley Fool

Recommendation and review posted by Bethany Smith

First FDA-approved CRISPR-based gene therapy cleared for 2nd indication – LabPulse

First FDA-approved CRISPR-based gene therapy cleared for 2nd indication  LabPulse

See the original post:
First FDA-approved CRISPR-based gene therapy cleared for 2nd indication - LabPulse

Recommendation and review posted by Bethany Smith

CRISPR Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval of CASGEVY … – GlobeNewswire

CRISPR Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval of CASGEVY ...  GlobeNewswire

See the rest here:
CRISPR Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval of CASGEVY ... - GlobeNewswire

Recommendation and review posted by Bethany Smith

CRISPR Gene Editing And Its Role In Hematology | TheHealthSite.com – TheHealthSite

CRISPR Gene Editing And Its Role In Hematology | TheHealthSite.com  TheHealthSite

More:
CRISPR Gene Editing And Its Role In Hematology | TheHealthSite.com - TheHealthSite

Recommendation and review posted by Bethany Smith

Perspectives in FTD Research Webinar: Gene Therapy for FTD — What Do I Need to Know? | AFTD – AFTD

Perspectives in FTD Research Webinar: Gene Therapy for FTD -- What Do I Need to Know? | AFTD  AFTD

Excerpt from:
Perspectives in FTD Research Webinar: Gene Therapy for FTD -- What Do I Need to Know? | AFTD - AFTD

Recommendation and review posted by Bethany Smith

UK leads the way in cell and gene therapy – Research Professional News

UK leads the way in cell and gene therapy  Research Professional News

Read the original here:
UK leads the way in cell and gene therapy - Research Professional News

Recommendation and review posted by Bethany Smith

Charles River’s (CRL) New Launch to Boost Gene Therapy Programs – Yahoo Finance

Charles River's (CRL) New Launch to Boost Gene Therapy Programs  Yahoo Finance

Follow this link:
Charles River's (CRL) New Launch to Boost Gene Therapy Programs - Yahoo Finance

Recommendation and review posted by Bethany Smith

Understanding the impact of AI on the advancement of gene therapy development – pharmaphorum

Understanding the impact of AI on the advancement of gene therapy development  pharmaphorum

Read more here:
Understanding the impact of AI on the advancement of gene therapy development - pharmaphorum

Recommendation and review posted by Bethany Smith

UK maintains status as an attractive destination for advanced therapy clinical trials – BioPharma-Reporter.com

UK maintains status as an attractive destination for advanced therapy clinical trials  BioPharma-Reporter.com

See the original post here:
UK maintains status as an attractive destination for advanced therapy clinical trials - BioPharma-Reporter.com

Recommendation and review posted by Bethany Smith

Gene therapy TSHA-102 delivered to 1st child in REVEAL trial – Rett Syndrome News

Gene therapy TSHA-102 delivered to 1st child in REVEAL trial  Rett Syndrome News

See the article here:
Gene therapy TSHA-102 delivered to 1st child in REVEAL trial - Rett Syndrome News

Recommendation and review posted by Bethany Smith

AAV Vectors in Gene Therapy Market is Predicted to Observe Skyrocketed Growth During the Study Period (2019-2032 … – PR Newswire

AAV Vectors in Gene Therapy Market is Predicted to Observe Skyrocketed Growth During the Study Period (2019-2032 ...  PR Newswire

See the original post:
AAV Vectors in Gene Therapy Market is Predicted to Observe Skyrocketed Growth During the Study Period (2019-2032 ... - PR Newswire

Recommendation and review posted by Bethany Smith

Family pins hopes on gene therapy – The Recorder and Times

Family pins hopes on gene therapy  The Recorder and Times

Here is the original post:
Family pins hopes on gene therapy - The Recorder and Times

Recommendation and review posted by Bethany Smith

Testosterone Treatment and Fractures in Men with Hypogonadism | NEJM – nejm.org

Testosterone Treatment and Fractures in Men with Hypogonadism | NEJM  nejm.org

View original post here:
Testosterone Treatment and Fractures in Men with Hypogonadism | NEJM - nejm.org

Recommendation and review posted by Bethany Smith

History Timeline – The Cryonics Institute

1976 ROBERT ETTINGER FOUNDS THE CRYONICS INSTITUTE

Then in 1976 a separate organization was formed: the Cryonics Institute, to offer cryostasis services: careful preparation, cooling, and long term patient care in liquid nitrogen.

Our goal was maximum reliability and affordability. And we achieved it. The Cryonics Institute offers clear-cut advantages over all other providers. Such as:

Our prices are lower than any other organization in fact, the most affordable prices anywhere in the world. Our minimum whole-body suspension fee is $28,000. (For members at a distance, transportation costs and local help will be additional.) Our $28,000 fee is a one-time only payment, with no subsequent charges. Its easily funded by insurance or other means, and funds the best care available for our member patients. (For last-minute cases, where the patient was not signed up beforehand, we ordinarily charge $35,000 rather than $28,000, if arrangements can be worked out at all.)

Does that lower fee mean lower quality patient care or services? No. The major part of other organizations fees are earmarked for investment provisions totally unrelated to patient care and preparation. Methods and research differ, but overall we believe our procedures and policies give a better chance for patient survival than any other organizations and this web site will show you the detailed reasons why.

See for yourself. Read our FAQ and see The CI Advantage that compares the different cryonics organizations and why we think CI gives you and those you love the best possible chance for future survival. Remember: most CI members can afford the higher prices of other organizations for themselves and their families and often do give more, in bequests and donations. But weve chosen CI because we know its our best bet. And yours.

We have a unique, proven track record of financial security and stability. Price stability too. CI is the only organization with no debt, no stockholders, and no landlords. We own our patient care facilities outright, and all our officers and directors donate their services voluntarily. Were one of the oldest cryonics organizations in existence and the only such organization that has never raised its prices, even in high-inflation times like the late 70s and early 80s. Adjusting for inflation, our prices have actually steadily declined, and we expect this to continue.

Financially, we are the soundest cryonics organization in existence.

We have a uniquely flexible and rapid system of emergency patient care based on universally available networks of mortuary assistance (and often medical assistance). This means that in the critical early stages, we can bring qualified professionals to you faster than any other system to you, and to travelers, vacationers, and members throughout most of the world. In particular, London-based F.A. Albin & Sons funeral directors are trained, practiced, equipped, and prepared to fly a team anywhere in Europe on short notice to help European CI members or tourists and business travelers.

And finally, we provide a comprehensive source of information here on CIs website. The site youre reading will lead you to everything you need to know about the subject of cryonics, and more. It offers you free information, free books, the latest news, hundreds of links to thousands of sources covering health, science, cutting-edge medicine, nanotechnology, financial help and resources, and supportive people and organizations. And if thats not enough? We personally will answer any question you might have about cryonics or the Cryonics Institute directly by email, or direct you to someone who can. In the world of cryonics, this is the source to visit, and the place to be.

More:
History Timeline - The Cryonics Institute

Recommendation and review posted by Bethany Smith


Archives